Abstract:

The study examined the synergistic applicability of disruptive technologies on the financial performance of companies, with special regards to the roles of technological innovations play on the financial outcomes of pharmaceutical companies. Globally, pharmaceutical companies hugely invest in disruptive technological innovations and so the need arises to study the multiplier relationship between this development and the financial consequences of these companies, to find out whether these innovations have any significant synergistic benefits to the advancement or abatement of financial numbers. To achieve these objectives, Big Data Analytics, Internet of Medical Things (IoMT), 4D Bio-Printing, Artificial Intelligence, and Gamification were considered as the proxies for disruptive technologies, and their influences on the financial fortunes of the studied companies. To evaluate the degree of relationship, a descriptive research design was adopted, with data gathered through a 5 point scaled questionnaire. The data were analysed using multiple linear regression technique. The general result revealed a significant synergistic influence of the application of disruptive technologies on financial performance of companies. The outcome of the study further demonstrates that pharmaceutical companies' financial numbers are synergistically influenced by their ability to adopt disruptive technologies and innovative skills in enhancing operations.

Keywords: